Riboceine Rescues Auranofin-Induced Craniofacial Defects in Zebrafish.

Riboceine antioxidant auranofin craniofacial anomalies neural crest oxidative stress zebrafish

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
08 Dec 2021
Historique:
received: 08 11 2021
revised: 04 12 2021
accepted: 06 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 25 12 2021
Statut: epublish

Résumé

Craniofacial abnormalities are a common group of congenital developmental disorders that can require intensive oral surgery as part of their treatment. Neural crest cells (NCCs) contribute to the facial structures; however, they are extremely sensitive to high levels of oxidative stress, which result in craniofacial abnormalities under perturbed developmental environments. The oxidative stress-inducing compound auranofin (AFN) disrupts craniofacial development in wildtype zebrafish embryos. Here, we tested whether the antioxidant Riboceine (RBC) rescues craniofacial defects arising from exposure to AFN. RBC rescued AFN-induced cellular apoptosis and distinct defects of the cranial cartilage in zebrafish larvae. Zebrafish embryos exposed to AFN have higher expression of antioxidant genes

Identifiants

pubmed: 34943067
pii: antiox10121964
doi: 10.3390/antiox10121964
pmc: PMC8750187
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Clin Pharmacol. 2009 May;65(5):483-91
pubmed: 19183974
J Hazard Mater. 2019 Mar 5;365:430-439
pubmed: 30453236
PLoS One. 2015 Mar 11;10(3):e0116963
pubmed: 25760440
Metallomics. 2011 Sep;3(9):863-73
pubmed: 21755088
Toxicol Sci. 2009 Jun;109(2):217-27
pubmed: 19233942
Bull World Health Organ. 2004 Mar;82(3):213-8
pubmed: 15112010
PLoS One. 2020 Jul 31;15(7):e0233582
pubmed: 32735620
Neurotoxicol Teratol. 2018 Jul - Aug;68:1-12
pubmed: 29665402
Toxicol Sci. 2007 Apr;96(2):246-54
pubmed: 17205975
Proc Natl Acad Sci U S A. 1983 Feb;80(3):707-11
pubmed: 6572362
Biochem Pharmacol. 2003 Oct 15;66(8):1499-503
pubmed: 14555227
Am J Med Genet A. 2010 Jul;152A(7):1641-53
pubmed: 20583156
Drug Metab Pharmacokinet. 2004 Aug;19(4):297-302
pubmed: 15499198
Reprod Toxicol. 2007 Jul;24(1):31-41
pubmed: 17548185
Redox Biol. 2015 Dec;6:648-655
pubmed: 26584358
Sci Rep. 2015 Dec 16;5:18321
pubmed: 26671447
Hum Mol Genet. 2009 Feb 1;18(3):418-27
pubmed: 18996922
PLoS Genet. 2013;9(10):e1003857
pubmed: 24098154
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Cell Commun Signal. 2020 Mar 14;18(1):45
pubmed: 32169084
Thorax. 2004 Aug;59(8):713-21
pubmed: 15282395
Biochem Pharmacol. 2019 May;163:362-370
pubmed: 30849304
J Med Genet. 2020 Mar;57(3):195-202
pubmed: 31784481
Reprod Biol Endocrinol. 2012 Jun 29;10:49
pubmed: 22748101
Nat Commun. 2016 Jan 21;7:10328
pubmed: 26792133
Br J Pharmacol. 2013 May;169(2):437-48
pubmed: 23425096
Elife. 2019 Sep 30;8:
pubmed: 31566562
Free Radic Biol Med. 2001 Dec 1;31(11):1287-312
pubmed: 11728801
Food Chem Toxicol. 2020 Oct;144:111559
pubmed: 32640352
J Proteome Res. 2012 Dec 7;11(12):6111-23
pubmed: 23106691
Atherosclerosis. 2014 Dec;237(2):725-33
pubmed: 25463112
Eur J Clin Pharmacol. 1986;31(2):217-22
pubmed: 3803419
Birth Defects Res C Embryo Today. 2007 Sep;81(3):155-62
pubmed: 17963268
Bioessays. 1997 Jun;19(6):459-68
pubmed: 9204763
J Physiol. 2003 Oct 15;552(Pt 2):335-44
pubmed: 14561818
Alcohol Clin Exp Res. 1996 Sep;20(6):1071-6
pubmed: 8892529
Dev Dyn. 2020 Jan;249(1):88-111
pubmed: 31591788
Brain Behav Evol. 2005;66(4):266-80
pubmed: 16254415
Biochim Biophys Acta. 2016 Jun;1862(6):1147-58
pubmed: 26972049
J Assist Reprod Genet. 2019 Feb;36(2):325-334
pubmed: 30415468
J Appl Toxicol. 2017 May;37(5):602-610
pubmed: 27813112
Lancet. 2009 Nov 21;374(9703):1773-85
pubmed: 19747722
Antioxidants (Basel). 2021 Jul 17;10(7):
pubmed: 34356370
Hum Mol Genet. 2018 Sep 1;27(17):3002-3011
pubmed: 29860495
Am J Obstet Gynecol. 2020 Nov;223(5):753.e1-753.e14
pubmed: 32416155
Hum Mol Genet. 2015 Mar 15;24(6):1540-55
pubmed: 25378554
Sci Rep. 2019 Nov 11;9(1):16467
pubmed: 31712630

Auteurs

Megan Leask (M)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, The University of Auckland, Auckland 1010, New Zealand.

Catherine Carleton (C)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Department of Oral Sciences, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.

Bryony Leeke (B)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Trent Newman (T)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Joseph Antoun (J)

Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, The University of Auckland, Auckland 1010, New Zealand.
Department of Oral Sciences, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.

Mauro Farella (M)

Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, The University of Auckland, Auckland 1010, New Zealand.
Department of Oral Sciences, Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand.

Julia Horsfield (J)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, The University of Auckland, Auckland 1010, New Zealand.
Genetics Otago Research Centre, University of Otago, Dunedin 9016, New Zealand.

Classifications MeSH